Cleviprex IV therapy approved by FDA

Article Title: Cleviprex IV therapy approved by FDA
Article Snip: "...The Medicines Company recently received approval from the U.S. Food and Drug Administration (FDA) for Cleviprex (clevidipine butyrate) injectable emulsion for the reduction of blood pressure when oral therapy is not feasible or not desirable. Cleviprex is the first IV antihypertensive treatment approved in 10 years. Cleviprex is a dihydropyridine calcium channel blocker...."
Reference: www.modernmedicine.com